Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 45Colorectal Neoplasms 45Esophageal Neoplasms 28Esophageal Squamous Cell Carcinoma 24Stomach Neoplasms 22Pancreatic Neoplasms 19Colonic Neoplasms 18Adenocarcinoma Of Esophagus 15Carcinoma, Hepatocellular 14Neoplasm Metastasis 7Liver Neoplasms 6Cholangiocarcinoma 5Recurrence 4Locally Advanced Rectal Cancer 4Turcot syndrome 3Peritoneal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Breast Neoplasms 2Bites and Stings 2Adenocarcinoma 2Surgery 1Successful Conversion Rate of Operation 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Ductal Adenocarcinoma 1

Interventions

Cisplatin 8Carboplatin 8X-Rays 7Specimen Handling 7Phantoms, Imaging 7Magnetic Resonance Spectroscopy 6Cyclophosphamide 6sodium thiosulfate 5Vincristine 5Nuclear Medicine Department, Hospital 5Granulocyte Colony-Stimulating Factor 5Etoposide 5Doxorubicin 5Biopsy 5Melphalan 4Irinotecan 4Fluorouracil 4fludarabine 3Thiotepa 3Oxaliplatin 3Mesna 3Gemcitabine 3Filgrastim 3Busulfan 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatoblastoma × Neoadjuvant Therapy × Gastrointestinal × Clear all
NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
57 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡